Ipsen and Tercica Enter into Cross-Licensing and Equity Collaboration
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 75 (Table of Contents)
Published: 6 Sep-2006
DOI: 10.3833/pdr.v2006.i75.461 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Ipsen Group and Tercica entered into cross-licensing agreement in the field of endocrinology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS